TwinStrand Biosciences Announces $50 Million Series B to Expand the Adoption of its Duplex Sequencing Technology in Applications Requiring the Highest Sensitivity and Accuracy

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/3h6kiHp
via IFTTT